ArticleVaccine2010

Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV.

Rongxin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.